for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pfizer raises estimates for 2021 sales of COVID-19 vaccine to $33.5 bln

July 28 (Reuters) - Pfizer Inc on Wednesday raised its forecast for sales of the COVID-19 vaccine that it developed with Germany’s BioNTech to $33.5 billion from $26 billion, the second increase this year in the face of a global scramble for the shots. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up